| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.68B | 5.72B | 5.15B | 3.10B | 59.23M |
| Gross Profit | 1.56B | 1.48B | 1.35B | 1.20B | 17.78M |
| EBITDA | 1.01B | 961.39M | 889.37M | 785.87M | 16.50M |
| Net Income | 750.36M | 706.31M | 659.69M | 575.24M | -56.39M |
Balance Sheet | |||||
| Total Assets | 5.79B | 3.96B | 3.08B | 2.58B | 308.21M |
| Cash, Cash Equivalents and Short-Term Investments | 1.27B | 580.52M | 177.98M | 207.83M | 15.64M |
| Total Debt | 457.08M | 729.78M | 119.69M | 39.26M | 490.97M |
| Total Liabilities | 1.53B | 1.38B | 811.58M | 679.80M | 798.27M |
| Stockholders Equity | 4.25B | 2.58B | 2.26B | 1.91B | -476.27M |
Cash Flow | |||||
| Free Cash Flow | -60.35M | 53.77M | 370.34M | -41.69M | -47.58M |
| Operating Cash Flow | 172.13M | 390.08M | 403.88M | 138.94M | -47.58M |
| Investing Cash Flow | 112.01M | -505.64M | -192.89M | -328.36M | 42.53M |
| Financing Cash Flow | 640.62M | 112.35M | -240.79M | -24.01M | -1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$2.29B | 3.61 | 5.10% | 4.05% | 10.23% | 66.75% | |
73 Outperform | HK$13.37B | 5.90 | 9.57% | 4.43% | 10.89% | 2.02% | |
64 Neutral | HK$107.63B | 15.23 | 23.29% | 4.21% | -9.49% | 32.56% | |
61 Neutral | HK$8.06B | 4.77 | 12.17% | 4.60% | 6.00% | 114.75% | |
60 Neutral | HK$8.04B | 14.18 | 20.83% | 1.70% | ― | ― | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
48 Neutral | HK$348.15M | -1.28 | -7.92% | ― | -17.82% | 16.27% |